Inspire Medical Systems, Inc. (NYSE:INSP) is reporting third quarter financial results on Monday 2nd November 2020, after market close.
According to analysts surveyed by Thomson Reuters, INSP is expected to report 3Q20 loss of $ 0.72 per share from revenue of $ 22.75 million.
For the full year, analysts anticipate top line of $ 90.19 million, while looking forward to loss of $ 2.8 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 88.00 million ~ $ 92.00 million
Click Here For More Historical Outlooks Of Inspire Medical Systems, Inc.
Previous Quarter Performance
Inspire Medical Systems, Inc. announced loss for the second quarter of $ 0.88 per share, from the revenue of $ 12.18 million. The quarterly revenues decreased 32.45 percent compared with the same quarter last year. Wall street analysts are predicting, INSP to report 2Q20 loss of $ 1.10 per share from revenue of $ 7.85 million. The bottom line results beat street analysts by $ 0.22 or 20.00 percent, at the same time, top line results outshined analysts by $ 4.33 million or 55.16 percent.
Stock Performance
On Friday, shares of Inspire Medical Systems, Inc. has traded high as $ 123.43 and has cracked $ 115.00 on the downward trend, reaching $ 119.43 with volume of 281.70 thousand shares.
According to the previous trading day, closing price of $ 119.43, representing a 205.67 % increase from the 52 week low of $ 40.53 and a 8.37 % decrease over the 52 week high of $ 135.20.
The company has a market capital of $ 3.20 billion and is part of the Healthcare sector and Medical Devices industry.
Recent Analyst recommendations
- On 22nd September 2020, initiated by JPMorgan Chase & Co. at Overweight rating, with $ 148.00 target price.
- On 18th September 2020, maintained by Piper Sandler at Overweight rating, with $ 137.00 target price.
- On 9th September 2020, maintained by SVB Leerink at Outperform rating, with $ 150.00 target price.
Conference Call
Inspire Medical Systems, Inc. will be hosting a conference call at 5:00 PM eastern time on 2nd November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.inspiresleep.com
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patients breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
